Skip to main content
Open Forum Infectious Diseases logoLink to Open Forum Infectious Diseases
. 2019 Dec 8;6(12):ofz500. doi: 10.1093/ofid/ofz500

Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients

Flaminia Olearo 1, Huyen Nguyen 2,3, Fabrice Bonnet 4,5, Sabine Yerly 6, Gilles Wandeler 7, Marcel Stoeckle 8, Matthias Cavassini 9, Alexandra Scherrer 2,3, Dominique Costagliola 10, Patrick Schmid 11, Huldrych F Günthard 2,3, Enos Bernasconi 12, Jürg Boeni 3, Antonella D’arminio Monforte 13, Maurizio Zazzi 14, Barbara Rossetti 15, Didier Neau 5, Pantxika Bellecave 16, Bart Rijnders 17, Peter Reiss 17, Ferdinand Wit 17, Roger Kouyos 2,3, Alexandra Calmy 1
PMCID: PMC6899347  PMID: 31832485

In “Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients” Open Forum Infectious Diseases, Volume 6, Issue 10, October 2019, ofz330, https://doi.org/10.1093/ofid/ofz330, the surname of a co-author, Dominique Costagliola, was misspelled. This was corrected in the new version of the manuscript.


Articles from Open Forum Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES